Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Cycad Group: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Cycad Group
Cycad Group
Active
Website
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Cycad Group.
PF
Paul F. Glenn
CHAIRMAN & DIRECTOR
RJ
Robert J. Balch
Vice President
KL
K. Leonard Judson
President and Managing Director
MR
Mark R. Collins
Executive
Leadership Team
Key people at Cycad Group.
PF
Paul F. Glenn
CHAIRMAN & DIRECTOR
RJ
Robert J. Balch
Vice President
KL
K. Leonard Judson
President and Managing Director
MR
Mark R. Collins
Executive
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Oct 9, 2017
ImaginAb
$8.0M Other Equity
Adage Capital Management
dRx Capital
, Nextech Invest
, Jeffrey Bluestone
, James Pallotta
Oct 1, 2017
Visterra
$24.0M Series C
—
Access Biotechnology
,
Atlas Venture
,
GE Ventures
, InterWest
,
Wildcat Ventures
,
Alexandria Venture Investments
,
Allegheny Financial Group
,
Bill & Melinda Gates Foundation
,
CTI Life Sciences Fund
,
Flagship Pioneering
,
MRL Ventures Fund
,
Omega Funds
, Polaris Partners
,
Serum Institute of India
, Temasek
Aug 1, 2017
UNITY Biotechnology
$35.0M Series B
ARCH Venture Partners
,
Venrock
, Fidelity Management & Research Company
, Partner Fund Management
Foundry Group
,
High Alpha
,
LOI Venture
,
Menlo Ventures
,
Vivo Capital
, Rudy Gadre
,
Bezos Expeditions
,
Founders Fund
,
Invus Opportunities
,
Mayo Clinic
,
Pivotal Alpha Limited
,
Three Lakes Partners
,
Vulcan Capital
,
WuXi AppTec
Oct 1, 2014
Visterra
$30.0M Series B
Janelle Anderson
, Lincoln Chee Wang Jin
Access Biotechnology
,
Atlas Venture
,
GE Ventures
, InterWest
,
Wildcat Ventures
,
Alexandria Venture Investments
,
Flagship Ventures
,
Omega Funds
, Polaris Partners
May 11, 2014
ImaginAb
$21.0M Series B
Merieux Equity Partners
Nextech Invest
,
Novartis
Oct 16, 2013
SOFIE
$5.0M Series A
Tata Industries
MRM Capital
Oct 1, 2012
Genocea Biosciences
$30.0M Series C
—
Aberdare Ventures
,
Acorn Bioventures
,
Atlas Venture
,
Borealis Ventures
,
Highbury Group
,
Johnson & Johnson Innovation
,
Kurma Partners
,
SR One
,
Auriga Partners
, Trevor Mundel
,
CVF
,
Johnson & Johnson Innovation
,
Lux Capital
,
Morningside
, MP Healthcare Venture Management
, Polaris Partners
,
Skyline Ventures
Apr 4, 2012
OvaScience
$37.0M Series B
John Simon
BBT Capital Management Advisors
,
Bessemer Venture Partners
,
Hunt BioVentures
,
Longwood Fund
, RA Capital Management
Mar 27, 2012
ImaginAb
$12.5M Series A
Campbell Murray
Merieux Equity Partners
,
Momentum Biosciences
, Nextech Invest
Jan 1, 2011
Genocea Biosciences
$35.0M Series B
—
Atlas Venture
,
Borealis Ventures
,
Johnson & Johnson Innovation
,
SR One
,
Auriga Partners
,
Johnson & Johnson Innovation
,
Lux Capital
, Morningside Ventures
, MP Healthcare Venture Management
, Polaris Partners
, Stephen J. Hoffman
Dec 9, 2010
SOFIE
$2.0M Other Equity
Cycad Group
—
Sep 11, 2010
Solaria
$65.0M Debt / Series D Extension
—
Adams Street Partners
,
CMEA Capital
,
DBL Partners
,
EDF Energy North America
,
Mitsui & Co. Global Investment
,
NGEN Partners
,
Savitr Capital
,
Sigma Partners
,
Western Technologies